Remove tag physician-practices
article thumbnail

PharmDs – Crucial to Chronic Care Management Services: A Doctor’s Perspective

PharmD Live

Chronic care services managed by a doctor of pharmacy, PharmD, is a critical addition to a medical practice, but they are not widely engaged with these responsibilities. The author is a residency-trained, board-certified emergency medicine physician and offers a different perspective. PharmDs Earn MVP Status .

article thumbnail

2021 Highlights of Chronic Care Medicine

PharmD Live

Virtual care, normalized by the pandemic, is now common practice for providers and patients, especially at the primary care level–a boon in 2021 for underserved chronic care populations. With an annual price per patient of nearly $56,000 per year, patients’ families are looking for solutions for their loved ones–with a huge price tag.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Osteopathic Medicine and Surviving Your Second Year of Medical School with Dr. Bryce Brohol ?

The Physician Pharmacist

️ Podcasts are a great way to learn about a variety of topics, and The Physician Pharmacist Podcast is no exception. However, after observing physicians and residents on rounds during his introductory rotations in pharmacy school, he had an epiphany and realized that medicine was what he wanted to do. Here's a featured episode below!

article thumbnail

Twenty Women Leaders In Healthcare Industry

PharmaShots

An elected member of Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI), she also serves fellow of the American Gastroenterological Association. She has also been appointed as the president of the American Pancreas Association (APA). LinkedIn Total experience: 16 yrs.

FDA 40
article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

This round-trip shipping was especially challenging during the early days of the COVID-19 pandemic, which coincided with initial attempts to establish CAR T-cell therapies in daily practice. This is in addition to its considerable price tag. This is variable and to some extent unpredictable.

article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.